Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1978 1
1979 1
1987 1
1992 1
1994 1
1995 3
1997 4
1998 4
1999 6
2000 3
2001 1
2008 1
2009 1
2010 1
2011 4
2012 3
2013 1
2014 4
2015 8
2016 11
2017 6
2018 6
2019 4
2020 13
2021 10
2022 11
2023 13
2024 11
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Howard JF Jr, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Lowcock R, Vanderkelen M, Leite MI; RAISE Study Team. Howard JF Jr, et al. Lancet Neurol. 2023 May;22(5):395-406. doi: 10.1016/S1474-4422(23)00080-7. Lancet Neurol. 2023. PMID: 37059508 Clinical Trial.
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration.
Ryan SK, Zelic M, Han Y, Teeple E, Chen L, Sadeghi M, Shankara S, Guo L, Li C, Pontarelli F, Jensen EH, Comer AL, Kumar D, Zhang M, Gans J, Zhang B, Proto JD, Saleh J, Dodge JC, Savova V, Rajpal D, Ofengeim D, Hammond TR. Ryan SK, et al. Among authors: comer al. Nat Neurosci. 2023 Jan;26(1):12-26. doi: 10.1038/s41593-022-01221-3. Epub 2022 Dec 19. Nat Neurosci. 2023. PMID: 36536241 Free PMC article.
Telemedicine-based inspiratory muscle training and walking promotion with lung cancer survivors following curative intent therapy: a parallel-group pilot randomized trial.
Ha DM, Comer A, Dollar B, Bedoy R, Ford M, Gozansky WS, Zeng C, Arch JJ, Leach HJ, Malhotra A, Prochazka AV, Keith RL, Boxer RS. Ha DM, et al. Among authors: comer a. Support Care Cancer. 2023 Sep 1;31(9):546. doi: 10.1007/s00520-023-07999-7. Support Care Cancer. 2023. PMID: 37656252 Free PMC article. Clinical Trial.
Extended-release oxybutynin.
Comer AM, Goa KL. Comer AM, et al. Drugs Aging. 2000 Feb;16(2):149-55; discussion 156-7. doi: 10.2165/00002512-200016020-00008. Drugs Aging. 2000. PMID: 10755330 Review.
Identifying Goals of Care.
Comer A, Fettig L, Torke AM. Comer A, et al. Med Clin North Am. 2020 Sep;104(5):767-775. doi: 10.1016/j.mcna.2020.06.002. Med Clin North Am. 2020. PMID: 32773044 Free PMC article. Review.
Evolution of a discipline-The changing face of anatomy.
Organ JM, Comer AR. Organ JM, et al. Among authors: comer ar. Anat Rec (Hoboken). 2022 Apr;305(4):766-771. doi: 10.1002/ar.24901. Epub 2022 Feb 22. Anat Rec (Hoboken). 2022. PMID: 35194948 Free PMC article.
Challenging Neuromuscular Disease Cases.
Bodkin C, Comer A, Felker M, Gutmann L, Jones KA, Kincaid J, Payne KK, Skinner B. Bodkin C, et al. Among authors: comer a. Semin Neurol. 2022 Dec;42(6):716-722. doi: 10.1055/a-1985-0230. Epub 2022 Nov 23. Semin Neurol. 2022. PMID: 36417990
Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Kaminski HJ, Mantegazza R, Sacconi S, Utsugisawa K, Vu T, Boehnlein M, Gayfieva M, Greve B, Woltering F, Vissing J; MG0004 study investigators. Bril V, et al. J Neurol. 2025 Mar 19;272(4):275. doi: 10.1007/s00415-025-12958-9. J Neurol. 2025. PMID: 40105996 Free PMC article. Clinical Trial.
137 results